In mid-December 2021, the United States Department of Health and Human Services Office of Inspector General (HHS OIG) released a data brief that found many Medicare beneficiaries are not receiving medication to treat their opioid use disorder. Currently, three different medications are approved for the treatment of opioid use disorder: buprenorphine, methadone, and naltrexone. Beneficiaries … Continue reading HHS OIG Report Finds Many Medicare Beneficiaries Are Not Receiving Medication to Treat Opioid Use Disorder